Frontlight ResearchEarly access
Trial site
Virginia Oncology Associates
- 8running trials
- 3closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Metastatic breast cancer2 trials
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Melanoma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Status
- Recruiting5 trials
- Active, not recruiting3 trials
- Completed3 trials
- Lead sponsor
- Pfizer6 trials
- US Oncology Research2 trials
- Amgen1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
Closed trials
Completed
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026